80
Views
5
CrossRef citations to date
0
Altmetric
Original Research

KLF11 Expression Predicts Poor Prognosis in Glioma Patients

ORCID Icon, , , & ORCID Icon
Pages 2923-2929 | Published online: 28 Jun 2021

References

  • Ostrom QT, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan JS. Epidemiology of intracranial gliomas. Prog Neurol Surg. 2018;30:1–11.
  • Pellerino A, Franchino F, Soffietti R, Ruda R. Overview on current treatment standards in high-grade gliomas. Q J Nucl Med Mol Imaging. 2018;62(3):225–238. doi:10.23736/S1824-4785.18.03096-0
  • Cheng L, Shi L, Dai H. Bioinformatics analysis of potential prognostic biomarkers among Kruppel-like transcription Factors (KLFs) in breast cancer. Cancer Biomark. 2019;26(4):411–420. doi:10.3233/CBM-190199
  • Cook T, Gebelein B, Mesa K, Mladek A, Urrutia R. Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J Biol Chem. 1998;273(40):25929–25936. doi:10.1074/jbc.273.40.25929
  • Wang G, Li X, Tian W, et al. Promoter DNA methylation is associated with KLF11 expression in epithelial ovarian cancer. Genes Chromosomes Cancer. 2015;54(7):453–462. doi:10.1002/gcc.22257
  • Ji Q, Li Y, Zhao Q, et al. KLF11 promotes gastric cancer invasion and migration by increasing Twist1 expression. Neoplasma. 2019;66(1):92–100. doi:10.4149/neo_2018_180325N201
  • Xi Z, Xue Y, Zheng J, Liu X, Ma J, Liu Y. WTAP expression predicts poor prognosis in malignant glioma patients. J Mol Neurosci. 2016;60(2):131–136. doi:10.1007/s12031-016-0788-6
  • Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
  • Limame R, Op de Beeck K, Lardon F, De Wever O, Pauwels P. Kruppel-like factors in cancer progression: three fingers on the steering wheel. Oncotarget. 2014;5(1):29–48.
  • Zhang Y, Hao J, Zheng Y, et al. Role of Kruppel-like factors in cancer stem cells. J Physiol Biochem. 2015;71(1):155–164. doi:10.1007/s13105-015-0381-4
  • Son B, Jeon J, Lee S, et al. Radiotherapy in combination with hyperthermia suppresses lung cancer progression via increased NR4A3 and KLF11 expression. Int J Radiat Biol. 2019;95(12):1696–1707. doi:10.1080/09553002.2019.1665213
  • Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M. Recent progress in the research of suicide gene therapy for malignant glioma. Neurosurg Rev. 2019.
  • Fecci PE, Sampson JH. The current state of immunotherapy for gliomas: an eye toward the future. J Neurosurg. 2019;131(3):657–666. doi:10.3171/2019.5.JNS181762
  • Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284–297. doi:10.1007/s13311-017-0519-x
  • Music D, Dahlrot RH, Hermansen SK, et al. Expression and prognostic value of the WEE1 kinase in gliomas. J Neurooncol. 2016;127(2):381–389. doi:10.1007/s11060-015-2050-4
  • Zeng J, Zhang XK, Chen HD, Zhong ZH, Wu QL, Lin SX. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas. Oncotarget. 2016;7(8):8944–8955. doi:10.18632/oncotarget.6884